Abstract:Alport syndrome (AS) is an inherited progressive disease caused by mutations in genes encoding for the 3, 4 and 5 chains, which are an essential component of type IV collagen and are required for formation of the glomerular basement membrane. However, the underlying etiology of AS remains largely unknown, and the aim of the present study was to examine the genetic mechanisms in AS. Induced pluripotent stem cells (iPSCs) were generated from renal tubular cells. The Illumina HiSeq 2000 system and iTRAQ-coupled 2D liquid chromatography-tandem mass spectrometry were used to generate the sequences of microRNAs (miRNAs), transcripts and proteins from AS-iPSCs. Integration of miRNA, transcript and protein expression data was used to construct regulatory networks and identify specific miRNA targets amongst the transcripts and proteins. Relative quantitative proteomics using iTRAQ technology revealed 383 differentially abundant proteins, and high-throughput sequencing identified 155 differentially expressed miRNAs and 1,168 differentially expressed transcripts. Potential miRNA targets were predicted using miRanda, TargetScan and Pictar. All target proteins and transcripts were subjected to network analysis with miRNAs. Gene ontology analysis of the miRNAs and their targets revealed functional information on the iPSCs, including biological process and cell signaling. Kyoto Encyclopedia of Genes and Genomes pathways analysis revealed that the transcripts and proteins were primarily enriched in metabolic and cell adhesion molecule pathways. In addition, the network maps identified hsa-miRNA (miR)-4775 as a prominent miRNA that was associated with a number of targets. Similarly, the prominent ELV-like protein 1-A and epidermal growth factor receptor (EGFR)-associated transcripts were identified. Reverse transcription-quantitative polymerase chain reaction analysis was used to confirm the upregulation of hsa-miR-4775 and EGFR. The integrated approach used in the present study provided a comprehensive molecular characterization of AS. The results may also further understanding of the genetic pathogenesis of AS and facilitate the identification of candidate biomarkers for AS.

Generation of an Induced Pluripotent Stem Cell Line (Shcdnri001-A) from a Patient with X-linked Alport Syndrome Carrying a Heterozygous P.g409s (c. 1225 G > A) Mutation in the COL4A5 Gene

Establishment of an induced pluripotent stem cell line from a patient with X-linked Alport syndrome carrying a hemizygous splicing variant (NM_033380; c.929[exon 16]delG) in the collagen type IV alpha 5 chain gene

Establishment of the Induced Pluripotent Stem Cell Line (Nckdi005-A) from a Male Patient with Alport Syndrome Carrying a Homozygous Frameshift Mutation in the COL4A4 Gene.

Generation of the Induced Pluripotent Stem Cell Line (Nckdi004-A) from a 17-Year-old Patient with Alport Syndrome Carriny a Homozygous Mutation in COL4A3 Gene

Generation of Induced Pluripotent Stem Cell Line (Nckdi001-A) from a 19-Year-old Patient with a Novel COL4A5 Gene Mutation in Alport Syndrome

Generation of an Induced Pluripotent Stem Cell Line from a Brugada Syndrome Patient Carrying SCN5A/c.3118G>C Mutation

Establishment of Induced Pluripotent Stem Cell Line (Zzui009-A) from an Alzheimer's Disease Patient Carrying a PSEN1 Gene Mutation

Generation of Induced Pluripotent Stem Cell Line (Zzui0012-A) from a Patient with Fahr's Disease Caused by a Novel Mutation in SLC20A2 Gene.

A Novel Missense Mutation of COL4A5 Gene Alter Collagen IV Α5 Chain to Cause X-linked Alport Syndrome in a Chinese Family.

Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation

Establishment of Microrna, Transcript and Protein Regulatory Networks in Alport Syndrome Induced Pluripotent Stem Cells

A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene

Generation of an induced pluripotent stem cell line from an Alstrom Syndrome patient with <i>ALMS1</i> mutation (c.3902C > A, c.6436C > T) and a gene correction isogenic iPSC line

Determination of the Pathogenicity of a Novel COL4A5 Missense Variant by CRISPR-Cas9 in Kidney Podocytes.

Aberrant Splicing of COL4A5 Intronic Variant Contribute to the Pathogenesis of X-Linked Alport Syndrome: A Case Series

Detection of a Novel Mutation in COL4A5 Gene from a Chinese Family with X-linked Alport Syndrome

Prenatal Diagnosis And Genetic Counseling Of A Chinese Alport Syndrome Kindred

Identification of a Novel COL4A5 Mutation in the Proband Initially Diagnosed As IgAN from a Chinese Family with X-linked Alport Syndrome.

Generation of induced pluripotent stem cell line (XDCMHi001-A) from an Ankylosing spondylitis patient with JAK2 mutation.

A Novel Splice Site Mutation In The Col4a5 Gene In A Chinese Female Patient With Rare Ocular Abnormalities

iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome